Remission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of Bortezomib

<div>Evolution of laboratory parameters demonstrating patient’s clinical course during the relapsed TTP episode. Major therapies delivered have been indicated. LDH: lactate dehydrogenase; PEX: plasma exchange.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Remission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of Bortezomib 